Erythropoiesis-stimulating agents (ESAs)
Title
Date Published
Treatment of anemia with darbepoetin alfa in heart failure.
May 1, 2010
Cardiovascular risks of anemia correction with erythrocyte stimulating agents: should blood viscosity be monitored for risk assessment?
April 1, 2010
Evolving regulatory landscape with erythropoiesis-stimulating agents and impact on managed care.
March 1, 2010
Erythropoietic stimulating agents.
March 1, 2010
Anti-epoetin-antibody-induced anemia in a child with chronic renal failure.
February 18, 2010
Anti-erythropoietin antibodies followed by endogenous erythropoietin production in a dialysis patient.
January 21, 2010
Erythropoiesis-stimulating agents for anaemia in chronic heart failure patients.
January 20, 2010
Initiation of anaemia management in patients with chronic kidney disease not on dialysis in the Veterans Health Administration.
January 18, 2010
Erythropoiesis stimulating agent administration improves survival after severe traumatic brain injury: a matched case control study
January 1, 2010
Preoperative very short-term, high-dose erythropoietin administration diminishes blood transfusion rate in off-pump coronary artery bypass: a randomized blind controlled study.
December 29, 2009
A meta-analysis of erythropoiesis-stimulating agents in anaemic patients with chronic heart failure.
December 22, 2009
Anemia response and safety to epoetin-beta treatment in patients with neoadjuvant therapy prior to primary digestive tract tumor surgery.
December 12, 2009
Dose reduction of epoetin-alpha in the prevention of chemotherapy-induced anaemia.
November 17, 2009
A peptide-based erythropoietin-receptor agonist for pure red-cell aplasia.
November 5, 2009
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease.
October 30, 2009
Meeting new challenges in the management of anemia of chronic kidney disease through collaborative care with pharmacists.
October 13, 2009
Use of agents stimulating erythropoiesis in digestive diseases
October 7, 2009
Anemia management with darbepoetin-alfa in outpatient hemodialysis patients switched from epoetin-alfa: A community hospital experience
September 29, 2009
Update on the use of erythropoiesis- stimulating agents (ESAs) for the management of anemia of multiple myeloma and lymphoma
September 2, 2009
Erythropoietin in patients with acute coronary syndrome and its cardioprotective action after percutaneous coronary intervention
August 19, 2009